Ansbert Gadicke

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Ansbert Gadicke

Earlier roles on record: Board Member at Cullinan Therapeutics, Inc. (CGEM) until November 1, 2022. Cullinan Therapeutics, Inc. reported in an 8-K filed November 2, 2022 that Ansbert Gadicke resigned as director, effective November 1, 2022.

“Also on November 1, 2022, Ansbert Gadicke, M.D. notified the Board of his intention to resign as a director effective as of November 1, 2022.”

Cullinan Therapeutics, Inc. Form 8-K, filed November 2, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Ansbert Gadicke's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Cullinan Therapeutics, Inc. (CGEM)
Board Member

Proxy statement

2016-01-01–2022-11-01

Company network

Recorded roles and call appearances connecting this person to public companies.

Cullinan Therapeutics, Inc.

CGEM

Board Member

2016-01-01–2022-11-01

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: director Cullinan Therapeutics, Inc. (CGEM)
2022-11-01